SPOREs : Current SPORE Programs : Lung

Organization of the Organ Systems Branch
Overview, organization, staff listing and contact information

Current SPORE Programs
Abstracts and Cores of currently funded SPOREs

Information for the Public
Information for the public interested in activities of the SPORE program and frequently asked questions

PART Program
Information about the Patient Advocate Research Team Program

Information for Applicants
Information for researchers interested in applying for the SPORE program

IntraSPORE Communications
(access restricted to SPORE Investigators)

[ SPOREs: Brain | Breast | GI | GU | GYN | Head and Neck | Leukemia | Lung | Lymphoma | Myeloma | Ovarian | Pancreatic | Prostate | Skin ]

Lung SPOREs

While the mortality rate has declined among most population groups over the past decade, cancers of the lung and bronchus are still the leading cause of cancer death among both males and females in the United States. According to estimates of the American Cancer Society, approximately 169,400 new cases of lung and bronchus cancer and 154,900 deaths were expected to be reported in the year 2002. The high mortality rate is due largely to the fact that a majority of these cancers are not detected until the disease has reached an advanced stage, when treatment is less effective. Because of the huge burden of lung cancer in terms of morbidity and mortality, lung cancer was an early focus of the SPORE Program. Three Lung SPOREs have been funded since 1992 and additional SPOREs were added raising the number to six. In the year 2003, the plan is to increase the number of Lung Cancer SPOREs to seven.

To view the abstracts for the P50 SPOREs, please click on the name/address below.

Clinical Trials

The page is maintained by: Website Contact